NAM Unveils Ad Campaign to Oppose President Trump’s Proposed Drug Price Controls

The National Association of Manufacturers (NAM) has launched a new, seven-figure television and digital ad campaign aimed at potential rules to address drug pricing through International Price Indexing.

“As the nation continues to battle the COVID-19 pandemic, we should not be enacting policies that could potentially stifle pharmaceutical innovation,” said NAM President and CEO Jay Timmons. 8/4/2020